4.3 Article

Analysis of SDC2 gene promoter methylation in whole blood for noninvasive early detection of colorectal cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

Epigenetics and its therapeutic potential in colorectal cancer

Mahsa Akbari Oryani et al.

Summary: Colorectal cancer is the leading cause of cancer-related death worldwide. Epigenetics refers to changes in the chromosome rather than the DNA sequence. Non-coding RNAs play a role in epigenetic regulation in colorectal cancer. Targeting epigenetic mediators may improve the survival rate of colorectal cancer patients.

EPIGENOMICS (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Global colorectal cancer burden in 2020 and projections to 2040

Yue Xi et al.

Summary: Colorectal cancer is a major global public health challenge with higher incidence rates in developed countries and increasing trends in middle- and low-income countries. The rise of early-onset colorectal cancer is also seen. Increasing awareness, promoting healthy lifestyle choices, and implementing global screening programs are crucial in reducing the morbidity and mortality of colorectal cancer in the future.

TRANSLATIONAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial

Chang Woo Kim et al.

Summary: This trial aims to investigate the clinical performance of a device that allows quantitative detection of a single DNA marker, SDC2 methylation, in human stool DNA in asymptomatic populations. The results of this trial are expected to be beneficial for CRC screening and may help make colonoscopy a selective procedure used only in populations with a high risk of CRC.

BMC GASTROENTEROLOGY (2021)

Review Biochemistry & Molecular Biology

Novel Methylation Biomarkers for Colorectal Cancer Prognosis

Alvaro Gutierrez et al.

Summary: Colorectal cancer is the third most common cancer globally, and biomarkers play a crucial role in diagnosis and predicting metastasis. Key signaling pathways associated with cancer progression include the MAPK pathway, p53 pathway, and TGF-beta pathway.

BIOMOLECULES (2021)

Article Oncology

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer

Weisong Zhang et al.

Summary: The study found that SDC2 and TFPI2 were highly methylated in CRC, and integrated detection of them in stool samples has the potential to be an effective and noninvasive tool for early screening of CRC.

CANCER MANAGEMENT AND RESEARCH (2021)

Review Medicine, General & Internal

Screening and prevention of colorectal cancer

Priyanka Kanth et al.

Summary: Mortality from colorectal cancer can be reduced through screening and early detection; current efforts and tools for screening have been advancing, but overall screening rates in the US are suboptimal.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Oncology

Screening for Colorectal Cancer Leading into a New Decade: The Roaring '20s for Epigenetic Biomarkers?

Helder Almeida-Lousada et al.

Summary: Colorectal cancer plays a significant role in cancer incidence and mortality worldwide, requiring improved screening methods for early detection and patient management. The three pillars of CRC screening include endoscopy, radiological imaging, and molecular assays, with biomarker-based screening methods showing promising advantages for the future.

CURRENT ONCOLOGY (2021)

Article Oncology

Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection

Zhiliang Chen et al.

Summary: The methylation levels in leukocytes do not affect the performance of plasma-based methylation test for colorectal cancer (CRC). The combination of methylated SEPT9 (mSEPT9) and methylated SDC2 (mSDC2) in plasma shows higher sensitivity and specificity in detecting CRC. This non-invasive and cost-effective method has the potential for early detection of CRC.

JOURNAL OF CANCER (2021)

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Medical Laboratory Technology

A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2

Guodong Zhao et al.

CLINICA CHIMICA ACTA (2020)

Review Genetics & Heredity

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

Beenish Rahat et al.

FRONTIERS IN GENETICS (2020)

Article Medicine, Research & Experimental

Crosstalk between tumor cells and lymphocytes modulates heparanase expression

Therese Rachell Theodoro et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Review Pathology

Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis-an update

Bela Molnar et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)

Review Genetics & Heredity

DNA Methylation Cancer Biomarkers: Translation to the Clinic

Warwick J. Locke et al.

FRONTIERS IN GENETICS (2019)

Article Oncology

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia

Feng Niu et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Review Oncology

Early detection of colorectal cancer: from conventional methods to novel biomarkers

Nasimeh Vatandoost et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)

Article Cell Biology

Epigenetic Determinants of Cancer

Stephen B. Baylin et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Review Medicine, Research & Experimental

DNA methylation as an early diagnostic marker of cancer (Review)

Yuanyuan Dong et al.

BIOMEDICAL REPORTS (2014)

Review Pathology

Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer

Adam E. Frampton et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)

Review Oncology

Colonoscopy for Colorectal Cancer Screening

Patrick E. Young et al.

JOURNAL OF CANCER (2013)

Article Oncology

Epigenetics and Colorectal Cancer Pathogenesis

Kankana Bardhan et al.

Cancers (2013)

Article Oncology

Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma

Allison Marion et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Review Medicine, General & Internal

Colorectal cancer screening

M. Bretthauer

JOURNAL OF INTERNAL MEDICINE (2011)

Article Biochemistry & Molecular Biology

Syndecan-2 Functions as a Docking Receptor for Pro-matrix Metalloproteinase-7 in Human Colon Cancer Cells

Heui-Young Ryu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)